347 related articles for article (PubMed ID: 23234470)
21. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
Vladeck DC
Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967
[No Abstract] [Full Text] [Related]
22. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
[No Abstract] [Full Text] [Related]
23. Company pays over $81m for allegedly promoting topiramate for unapproved uses.
Kmietowicz Z
BMJ; 2010 May; 340():c2848. PubMed ID: 20508021
[No Abstract] [Full Text] [Related]
24. The FDA, preemption, and the Supreme Court.
Glantz LH; Annas GJ
N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601
[No Abstract] [Full Text] [Related]
25. Pros and cons of off-label promotion investigations and prosecutions.
Loucks MK
Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
[No Abstract] [Full Text] [Related]
26. Drug risks and free speech--can Congress ban consumer drug ads?
Shuchman M
N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002
[No Abstract] [Full Text] [Related]
27. Assessing supplement safety--the FDA's controversial proposal.
Cohen PA
N Engl J Med; 2012 Feb; 366(5):389-91. PubMed ID: 22276780
[No Abstract] [Full Text] [Related]
28. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage?
Roman A
Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322
[No Abstract] [Full Text] [Related]
29. On access and accountability--two Supreme Court rulings on generic drugs.
Boumil MM; Curfman GD
N Engl J Med; 2013 Aug; 369(8):696-7. PubMed ID: 23923990
[No Abstract] [Full Text] [Related]
30. Repackaging cigarettes--will the courts thwart the FDA?
Bayer R; Gostin L; Marcus-Toll D
N Engl J Med; 2012 Nov; 367(22):2065-7. PubMed ID: 23151279
[No Abstract] [Full Text] [Related]
31. Prescribing records and the First Amendment--New Hampshire's data-mining statute.
Post R
N Engl J Med; 2009 Feb; 360(8):745-7. PubMed ID: 19228615
[No Abstract] [Full Text] [Related]
32. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Javitt GH; Stanley E; Hudson K
Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
[No Abstract] [Full Text] [Related]
33. A patient's right of privacy in computerized pharmacy records.
Mowery G
Univ Cincinnati Law Rev; 1998; 66(2):697-746. PubMed ID: 16211743
[No Abstract] [Full Text] [Related]
34. The strange allure of state "right-to-try" laws.
Zettler PJ; Greely HT
JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
[No Abstract] [Full Text] [Related]
35. The federal preemption debate in pharmaceutical labeling product liability actions.
Gross JM; Curry JA
Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
[No Abstract] [Full Text] [Related]
36. Off-label prescription advertising, the FDA and the First Amendment: a study in the values of commercial speech protection.
Klasmeier C; Redish MH
Am J Law Med; 2011; 37(2-3):315-57. PubMed ID: 21847884
[No Abstract] [Full Text] [Related]
37. Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder.
Chace MJ; Zhang F; Fullerton CA; Huskamp HA; Gilden D; Soumerai SB
J Clin Psychiatry; 2012 Nov; 73(11):1388-94. PubMed ID: 23146199
[TBL] [Abstract][Full Text] [Related]
38. False Claims Act prosecution did not deter off-label drug use in the case of neurontin.
Kesselheim AS; Darby D; Studdert DM; Glynn R; Levin R; Avorn J
Health Aff (Millwood); 2011 Dec; 30(12):2318-27. PubMed ID: 22147859
[TBL] [Abstract][Full Text] [Related]
39. Assessing the viability of a substantive due process right to in vitro fertilization.
Harv Law Rev; 2005 Jun; 118(8):2792-813. PubMed ID: 15988862
[No Abstract] [Full Text] [Related]
40. An unhealthy disregard.
Nat Med; 2010 Jun; 16(6):609. PubMed ID: 20526289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
